Geron Ownership | Who Owns Geron?

Overview Forecast RevenueFinancials Chart Transcripts

Geron Ownership Summary

Geron is owned by 72.97% institutional investors, 0.08% insiders, and 26.95% retail investors. Ra capital management is the largest institutional shareholder, holding 9.56% of GERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Geron shares.

GERN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Geron	72.97%	0.08%	26.95%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	63.77M	9.56%	$95.02M
Blackrock	46.55M	7.71%	$197.38M
Blackrock funding, inc. /de	47.32M	7.09%	$70.51M
Soleus capital management	41.51M	6.22%	$61.85M
Vanguard group	35.66M	5.35%	$47.07M
Deep track capital, lp	31.72M	4.75%	$47.26M
State street	30.50M	4.57%	$45.44M
Citadel advisors	21.58M	3.23%	$32.15M
Point72 asset management	20.46M	3.07%	$30.48M
Clearbridge investments	19.62M	2.94%	$29.23M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	578.00K	5.15%	$861.22K
Stempoint capital lp	6.65M	3.01%	$9.38M
Soleus capital management	41.51M	2.50%	$61.85M
Eversept partners, lp	18.83M	1.48%	$28.06M
Boxer capital	6.00M	1.34%	$25.44M
Vivo capital	8.67M	1.08%	$12.92M
Ra capital management	63.77M	1.01%	$95.02M
Deep track capital, lp	31.72M	0.77%	$47.26M
Pale fire capital se	4.89M	0.64%	$7.28M
Kynam capital management, lp	6.84M	0.63%	$10.19M

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	20.46M	0.04%	20.46M
Soleus capital management	41.51M	2.50%	18.22M
Citadel advisors	21.58M	0.01%	11.65M
Stempoint capital lp	6.65M	3.01%	5.69M
Clearbridge investments	19.62M	0.03%	5.38M

Top Sellers

Holder	Shares	% Assets	Change
Rtw investments, lp	-	-	-44.11M
Holocene advisors, lp	-	-	-22.20M
Adage capital partners gp	-	-	-21.80M
Vivo capital	8.67M	1.08%	-18.55M
Tcg crossover management	-	-	-17.39M

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	20.46M	0.04%	20.46M	$30.48M
Vanguard fiduciary trust	3.84M	0.00%	3.84M	$5.71M
J. goldman & co lp	610.66K	0.03%	610.66K	$909.88K
Two sigma advisers, lp	385.55K	0.00%	385.55K	$528.20K
Panagora asset management	360.85K	0.00%	360.85K	$537.66K

Sold Out

Holder	Change
Newedge advisors	-1.00
True wealth design	-4.00
Ifp advisors	-20.00
Smartleaf asset management	-64.00
Nelson, van denburg & campbell wealth management group	-96.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	255	-4.14%	486,830,840	1.73%	72	1.42%	123	29.47%	56	-41.05%
Dec 31, 2025	122	-53.96%	156,418,320	-69.15%	23	0.40%	34	-67.62%	40	-55.56%
Sep 30, 2025	125	-52.11%	130,616,668	-74.61%	19	0.33%	40	-68.25%	45	-37.50%
Jun 30, 2025	257	-6.20%	514,289,584	0.89%	77	1.32%	125	-10.71%	71	1.43%
Mar 31, 2025	14	-95.19%	143,280,723	-70.72%	21	0.39%	10	-93.51%	2	-96.97%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	20.05M	3.13%	-
State Street® SPDR® S&P® Biotech ETF	18.52M	2.89%	-183.05K
Vanguard US Total Market Shares ETF	17.83M	2.80%	17.67K
BioPharma Credit Ord	14.12M	2.22%	14.12M
iShares Russell 2000 ETF	12.81M	2.00%	108.01K
Vanguard Explorer Inv	10.17M	1.59%	1.39M
ClearBridge SMID Cap Growth	10.17M	1.59%	-
SPDR® S&P Biotech ETF	10.09M	1.58%	22.55K
Eventide Healthcare & Life Sciences I	7.07M	1.11%	-
Fidelity Select Biotechnology	6.49M	1.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 18, 2026	ROBERTSON MICHELLE	EVP, CHIEF FINANCIAL OFFICER	Sell	$19.12K
May 09, 2025	LAWLIS V BRYAN	-	Buy	$15.67K
Feb 27, 2025	Samuels Scott Alan	EVP, Chief Legal Officer	Buy	$24.15K
Feb 27, 2025	SCARLETT JOHN A	Chairman, President and CEO	Buy	$22.06K
Feb 27, 2025	Ziegler James	EVP, Chief Commercial Officer	Buy	$160.00K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	1
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	1	-

GERN Ownership FAQ

Who Owns Geron?

Geron shareholders are primarily institutional investors at 72.97%, followed by 0.08% insiders and 26.95% retail investors. The average institutional ownership in Geron's industry, Biotech Stocks , is 35.75%, which Geron exceeds.

Who owns the most shares of Geron?

Geron’s largest shareholders are Ra capital management (63.77M shares, 9.56%), Blackrock (46.55M shares, 7.71%), and Blackrock funding, inc. /de (47.32M shares, 7.09%). Together, they hold 24.37% of Geron’s total shares outstanding.

Does Blackrock own Geron?

Yes, BlackRock owns 7.71% of Geron, totaling 46.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 197.38M$. In the last quarter, BlackRock increased its holdings by 5.14M shares, a 12.41% change.

Who is Geron’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Geron’s biggest shareholder by percentage of total assets invested, with 5.15% of its assets in 578K Geron shares, valued at 861.22K$.

Who is the top mutual fund holder of Geron shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Geron shares, with 3.13% of its total shares outstanding invested in 20.05M Geron shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools